Rainer Jordon

Title: Rainer Jordon: Innovator in Polyoxazoline Chemistry

Introduction

Rainer Jordon is a notable inventor based in Munich, Germany. He has made significant contributions to the field of polymer chemistry, particularly in the development of polyoxazoline derivatives. His innovative work has implications for various applications, including drug delivery systems.

Latest Patents

Rainer Jordon holds a patent for "Polyoxazolines with inert terminating groups, polyoxazolines prepared from protected initiating groups and related compounds." This patent presents novel functional polyoxazoline derivatives that are synthesized by terminating polyoxazoline polymerization with inert chemical groups. The disclosure also highlights the synthesis of electrophilic initiators with protected functional groups that can survive the conditions of polymerization. These initiators are crucial for creating inert-terminal polyoxazoline derivatives and other polyoxazolines with active terminal groups. Additionally, the patent discusses polyoxazoline-lipid conjugates and liposomal compositions prepared using these conjugates, along with methods for preparing conjugates with target molecules.

Career Highlights

Rainer Jordon is currently associated with Serina Therapeutics, Inc., where he continues to advance his research in polymer chemistry. His work has garnered attention for its potential applications in the pharmaceutical industry, particularly in enhancing drug delivery mechanisms.

Collaborations

Rainer collaborates with esteemed colleagues, including Michael David Bentley and J Milton Harris. Their combined expertise contributes to the innovative research and development efforts at Serina Therapeutics.

Conclusion

Rainer Jordon's contributions to polyoxazoline chemistry exemplify the intersection of innovation and practical application in the field of polymer science. His work not only advances scientific knowledge but also holds promise for future developments in drug delivery systems.